Common Contracts
4 similar Separation Agreement contracts by Oculus Innovative Sciences, Inc., Ruthigen, Inc.
AMENDED SEPARATION AGREEMENTSeparation Agreement • February 24th, 2014 • Ruthigen, Inc. • Pharmaceutical preparations • California
This Amended Separation Agreement (this “Agreement”), by and between Ruthigen, Inc., a Delaware corporation (“Ruthigen”), and Oculus Innovative Sciences, Inc., a Delaware corporation (“Oculus” and, together with Ruthigen, the “Parties” and each, a “Party”), is made and entered into as of January 31, 2014, and shall be effective as of the closing of the IPO (as defined herein) (the “Effective Date”).
AMENDED SEPARATION AGREEMENTSeparation Agreement • February 6th, 2014 • Oculus Innovative Sciences, Inc. • Surgical & medical instruments & apparatus • California
This Amended Separation Agreement (this “Agreement”), by and between Ruthigen, Inc., a Delaware corporation (“Ruthigen”), and Oculus Innovative Sciences, Inc., a Delaware corporation (“Oculus” and, together with Ruthigen, the “Parties” and each, a “Party”), is made and entered into as of January 31, 2014, and shall be effective as of the closing of the IPO (as defined herein) (the “Effective Date”).
SEPARATION AGREEMENTSeparation Agreement • August 8th, 2013 • Oculus Innovative Sciences, Inc. • Surgical & medical instruments & apparatus • California
This Separation Agreement (this “Agreement”), by and between Ruthigen, Inc., a Nevada corporation (“Ruthigen”), and Oculus Innovative Sciences, Inc., a Delaware corporation (“Oculus” and, together with Ruthigen, the “Parties” and each, a “Party”), is made and entered into as of August 2, 2013, and shall be effective as of the closing of the IPO (as defined herein) (the “Effective Date”).
SEPARATION AGREEMENTSeparation Agreement • August 8th, 2013 • Ruthigen, Inc. • Pharmaceutical preparations • California
This Separation Agreement (this “Agreement”), by and between Ruthigen, Inc., a Nevada corporation (“Ruthigen”), and Oculus Innovative Sciences, Inc., a Delaware corporation (“Oculus” and, together with Ruthigen, the “Parties” and each, a “Party”), is made and entered into as of August 2, 2013, and shall be effective as of the closing of the IPO (as defined herein) (the “Effective Date”).
